Calcium Electroporation for Basal Cell Carcinomas - Proof of Concept Study

• Status: Recruiting
• Trial end date: 2022-02-22
• Target enrollment: 0
• Participant gender: All

Summary

25 patients with primary low-risk basal cell carcinoma treated with calcium electroporation

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bispebjerg Hospital
• Collaborator: Mirai Medical, Ireland
• Treatments: Calcium

Criteria

Inclusion Criteria:

Primary low risk basal cell carcinoma less than 3 cm in diameter

-

Exclusion Criteria:

Immunosuppression or organ transplant recipients Pregnancy or breastfeeding Allergy to local anesthetics